Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

NovaDx discovers osteoporosis drug opportunities

April 25, 1997

Potent, orally active ACAT inhibitors from Sankyo

April 24, 1997

Azko Nobel discloses antiglucocorticoids

April 24, 1997

Antioxidants/hypolipidemics from ADIR

April 24, 1997

Ono discloses ICE inhibitors

April 23, 1997

New agents for postmenopausal syndrome described by Lilly

April 23, 1997

Gensia Sicor and Sankyo collaborate in diabetes research

April 22, 1997

New selective estrogen receptor modulator from Lilly

April 22, 1997

Pfizer discovers potent, selective beta3-adrenoceptor full agonist

April 22, 1997

Astra Arcus develops selective CCK-A agonist with potential for obesity

April 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...